Latigo Biotherapeutics, Inc. (LTGO)
12.66
-0.35
(-2.69%)
USD |
NASDAQ |
Nov 06, 10:12
Latigo Biotherapeutics Total Assets (Quarterly) : 64.76M for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 64.76M |
| Date | Value |
|---|---|
| March 31, 2026 | 50.58M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Turn Therapeutics, Inc. | 16.96M |
| Journey Medical Corp. | 98.36M |
| ANI Pharmaceuticals, Inc. | 1.494B |
| Corcept Therapeutics, Inc. | 1.034B |
| Veru, Inc. | 37.03M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 52.26M |
| Shareholders Equity (Quarterly) | 12.50M |
| Debt to Equity Ratio | 2.500 |
| Current Ratio | 1.148 |